Brendan Smith


Mr. Smith offers more than 20 years of financial, operational and strategic leadership experience, including as CFO of Translate Bio.

Prior to CRISPR Therapeutics, Mr. Smith was the Chief Financial Officer & Corporate Strategy of Translate Bio, a leading mRNA company that was recently acquired by Sanofi for $3.2B. Mr. Smith is an accomplished e...


Roles at CRISPR Therapeutics

  • CFO

    October, 2021 - present

My work style

How I prefer to work

Qualities I value in my colleagues

Sign up to see more about the team at CRISPR Therapeutics

My pet peeves

My communication style

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.